Skip to Content

Mycophenolate Mofetil

In the US, Mycophenolate Mofetil (mycophenolate mofetil systemic) is a member of the drug class selective immunosuppressants and is used to treat Autoimmune Hepatitis, Bullous Pemphigoid, Cogan's Syndrome, Crohn's Disease, Dermatomyositis, Evan's Syndrome, Graft-versus-host disease, High Cholesterol, Inflammatory Bowel Disease, Linear IgA Disease, Multiple Sclerosis, Myasthenia Gravis, Nephrotic Syndrome, Organ Transplant - Rejection Prophylaxis, Pemphigoid, Pemphigus, Psoriatic Arthritis, Pulmonary Fibrosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ulcerative Colitis and Uveitis.

US matches:

UK matches:

Ingredient matches for Mycophenolate Mofetil

Mycophenolic Acid

Mycophenolate Mofetil (BANM, JAN, USAN) is known as Mycophenolic Acid in the US.


BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.